Difference between revisions of "LncRNAWiki:H"

From LncRNAWiki
Jump to: navigation, search
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !Name !Transcript ID !Alias !Description |- |''H19'' |NONHSAT017465 |Q96MK8,ENSG00000130600 |H19, impri...")
 
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 +
<div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;">
 +
Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] '''H''' [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']]
 +
</div>
 +
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
|-
 
|-
Line 5: Line 9:
 
!Alias
 
!Alias
 
!Description
 
!Description
 +
!Disease
 
|-
 
|-
 
|''H19''
 
|''H19''
 
|[[NONHSAT017465]]
 
|[[NONHSAT017465]]
−
|Q96MK8,ENSG00000130600
+
|"Q96MK8,ENSG00000130600"
−
|H19, imprinted maternally expressed transcript (non-protein coding)
+
|"H19, imprinted maternally expressed transcript (non-protein coding)"
 +
|bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor
 
|-
 
|-
 
|''H1FX-AS1''
 
|''H1FX-AS1''
Line 15: Line 21:
 
|FLJ34151
 
|FLJ34151
 
|H1FX antisense RNA 1
 
|H1FX antisense RNA 1
 +
|_
 
|-
 
|-
 
|''HAGLR''
 
|''HAGLR''
Line 20: Line 27:
 
|Mdgt
 
|Mdgt
 
|HOXD antisense growth-associated long non-coding RNA
 
|HOXD antisense growth-associated long non-coding RNA
 +
|neuroblastoma
 
|-
 
|-
 
|''HAND2-AS1''
 
|''HAND2-AS1''
 
|[[HAND2-AS1]]
 
|[[HAND2-AS1]]
−
|DEIN, NBLA00301, FLJ11539
+
|"DEIN, NBLA00301, FLJ11539"
 
|HAND2 antisense RNA 1 (head to head)
 
|HAND2 antisense RNA 1 (head to head)
 +
|neuroblastoma
 
|-
 
|-
 
|''HAR1A''
 
|''HAR1A''
 
|[[lnc-BIRC7-2:1]]
 
|[[lnc-BIRC7-2:1]]
−
|HAR1F, ENSG00000238820
+
|"HAR1F, ENSG00000238820"
 
|highly accelerated region 1A
 
|highly accelerated region 1A
 +
|Alzheimer's disease,Huntington's disease, schizophrenia
 
|-
 
|-
 
|''HAR1B''
 
|''HAR1B''
 
|[[ENST00000447910.2]]
 
|[[ENST00000447910.2]]
−
|HAR1R, ENSG00000231133
+
|"HAR1R, ENSG00000231133"
 
|highly accelerated region 1B
 
|highly accelerated region 1B
 +
|Huntington's disease, schizophrenia
 
|-
 
|-
 
|''HAS2-AS1''
 
|''HAS2-AS1''
 
|[[HAS2-AS1]]
 
|[[HAS2-AS1]]
−
|HASNT, NCRNA00077
+
|"HASNT, NCRNA00077"
 
|HAS2 antisense RNA 1
 
|HAS2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''HCCAT5''
 
|''HCCAT5''
 
|[[HCCAT5]]
 
|[[HCCAT5]]
−
|HTA, FJ222407
+
|"HTA, FJ222407"
 
|hepatocellular carcinoma associated transcript 5 (non-protein coding)
 
|hepatocellular carcinoma associated transcript 5 (non-protein coding)
 +
|hepatocellular carcinoma
 
|-
 
|-
 
|''HCG27''
 
|''HCG27''
 
|[[HCG27]]
 
|[[HCG27]]
−
|bPG299F13.9, bCX101P6.9, bQB115I13.2, FLJ40123
+
|"bPG299F13.9, bCX101P6.9, bQB115I13.2, FLJ40123"
 
|HLA complex group 27 (non-protein coding)
 
|HLA complex group 27 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''HCG4''
 
|''HCG4''
 
|[[HCG4]]
 
|[[HCG4]]
−
|HCGIV-10, HCGIV.9
+
|"HCGIV-10, HCGIV.9"
 
|HLA complex group 4 (non-protein coding)
 
|HLA complex group 4 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''HCG4B''
 
|''HCG4B''
 
|[[HCG4B]]
 
|[[HCG4B]]
−
|HCGIV-6, HCGIV.5, HCGIV-06, bCX67J3.3, Em:AB023056.16, bPG309N1.1, bQB90C11.3
+
|"HCGIV-6, HCGIV.5, HCGIV-06, bCX67J3.3, Em:AB023056.16, bPG309N1.1, bQB90C11.3"
 
|HLA complex group 4B (non-protein coding)
 
|HLA complex group 4B (non-protein coding)
 +
|_
 
|-
 
|-
 
|''HCG9''
 
|''HCG9''
 
|[[HCG9]]
 
|[[HCG9]]
−
|PERB11, HCGIX, HCGIX4, HCGIX-4
+
|"PERB11, HCGIX, HCGIX4, HCGIX-4"
 
|HLA complex group 9 (non-protein coding)
 
|HLA complex group 9 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''HCP5''
 
|''HCP5''
 
|[[HCP5]]
 
|[[HCP5]]
−
|D6S2650E, P5-1
+
|"D6S2650E, P5-1"
 
|HLA complex P5 (non-protein coding)
 
|HLA complex P5 (non-protein coding)
 +
|_
 
|-
 
|-
 
|''HEIH''
 
|''HEIH''
 
|[[HEIH]]
 
|[[HEIH]]
−
|LINC-HEIH, lncRNA-HEIH, LINC00848, HCCAT2
+
|"LINC-HEIH, lncRNA-HEIH, LINC00848, HCCAT2"
 
|hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA
 
|hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA
 +
|hepatocelluar carcinoma
 
|-
 
|-
 
|''HELLPAR''
 
|''HELLPAR''
Line 80: Line 99:
 
|LINC-HELLP
 
|LINC-HELLP
 
|HELLP associated long non-coding RNA
 
|HELLP associated long non-coding RNA
 +
|extravillous trophoblast
 
|-
 
|-
 
|''HEXA-AS1''
 
|''HEXA-AS1''
Line 85: Line 105:
 
|FLJ13315
 
|FLJ13315
 
|HEXA antisense RNA 1
 
|HEXA antisense RNA 1
 +
|_
 
|-
 
|-
 
|''HIF1A-AS1''
 
|''HIF1A-AS1''
Line 90: Line 111:
 
|5'aHIF-1A
 
|5'aHIF-1A
 
|HIF1A antisense RNA 1
 
|HIF1A antisense RNA 1
 +
|kidney cancer
 
|-
 
|-
 
|''HIF1A-AS2''
 
|''HIF1A-AS2''
 
|[[HIF1A-AS2]]
 
|[[HIF1A-AS2]]
−
|3'aHIF-1A, aHIF
+
|"3'aHIF-1A, aHIF"
 
|HIF1A antisense RNA 2
 
|HIF1A antisense RNA 2
 +
|kidney cancer
 
|-
 
|-
 
|''HNF1A-AS1''
 
|''HNF1A-AS1''
Line 100: Line 123:
 
|FLJ38690
 
|FLJ38690
 
|HNF1A antisense RNA 1
 
|HNF1A antisense RNA 1
 +
|lung adenocarcinoma, oesophageal adenocarcinoma
 
|-
 
|-
 
|''HNF4A-AS1''
 
|''HNF4A-AS1''
Line 105: Line 129:
 
|uc002xlx
 
|uc002xlx
 
|HNF4A antisense RNA 1
 
|HNF4A antisense RNA 1
 +
|_
 
|-
 
|-
 
|''HORMAD2-AS1''
 
|''HORMAD2-AS1''
 
|[[HORMAD2-AS1]]
 
|[[HORMAD2-AS1]]
−
|MTMR3-AS1, NONHSAG033653
+
|"MTMR3-AS1, NONHSAG033653"
 
|HORMAD2 antisense RNA 1
 
|HORMAD2 antisense RNA 1
 +
|_
 
|-
 
|-
 
|''HOTAIR''
 
|''HOTAIR''
 
|[[NONHSAT028508]]
 
|[[NONHSAT028508]]
−
|Gm16258, Hox antisense intergenic RNA, ENSG00000228630
+
|"Gm16258, Hox antisense intergenic RNA, ENSG00000228630"
 
|Hox antisense intergenic RNA
 
|Hox antisense intergenic RNA
 +
|B-cell neoplasms,breast cancer,cervical cancer,colon cancer,colorectal cancer,endometrial cancer,gastric cancer,hepatocelluar carcinoma,laryngeal squamous cell carcinoma,liver cancer,lung adenocarcinoma,nasopharyngeal carcinoma,non-small cell lung cancer,oesophageal squamous cell carcinoma,oral squamous cell carcinoma,pancreas cancer,rheumatoid arthritis,small cell lung cancer
 
|-
 
|-
 
|''HOTAIRM1''
 
|''HOTAIRM1''
 
|[[lnc-EVX1-12:1]]
 
|[[lnc-EVX1-12:1]]
−
|HIT06113, HIT92376, linc1548, ENSG00000233429
+
|"HIT06113, HIT92376, linc1548, ENSG00000233429"
−
|HOXA transcript antisense RNA, myeloid-specific 1
+
|"HOXA transcript antisense RNA, myeloid-specific 1"
 +
|_
 
|-
 
|-
 
|''HOTTIP''
 
|''HOTTIP''
 
|[[NONHSAT119717]]
 
|[[NONHSAT119717]]
−
|HOXA13as, HIT18844, NCRNA00213, ENSG00000243766
+
|"HOXA13as, HIT18844, NCRNA00213, ENSG00000243766"
 
|HOXA transcript at the distal tip
 
|HOXA transcript at the distal tip
 +
|hepatocelluar carcinoma
 
|-
 
|-
 
|''HOXA11-AS''
 
|''HOXA11-AS''
 
|[[NONHSAT119704]]
 
|[[NONHSAT119704]]
−
|HOXA cluster antisense RNA 5 (non-protein coding), HOXA-AS5, HOXA11 antisense RNA 1 (non-protein coding), HOXA11-AS1, HOXA11S, NCRNA00076, non-protein coding RNA 76, ENSG00000240990
+
|"HOXA cluster antisense RNA 5 (non-protein coding), HOXA-AS5, ""HOXA11 antisense RNA 1 (non-protein coding)"", HOXA11-AS1, HOXA11S, NCRNA00076, ""non-protein coding RNA 76"", ENSG00000240990"
 
|HOXA11 antisense RNA
 
|HOXA11 antisense RNA
 +
|glioma, ovarian cancer
 
|-
 
|-
 
|''HOXA-AS2''
 
|''HOXA-AS2''
 
|[[NONHSAT119676]]
 
|[[NONHSAT119676]]
−
|HOXA3as, ENSG00000253552
+
|"HOXA3as, ENSG00000253552"
 
|HOXA cluster antisense RNA 2
 
|HOXA cluster antisense RNA 2
 +
|gastric cancer
 
|-
 
|-
 
|''HOXA-AS3''
 
|''HOXA-AS3''
Line 140: Line 171:
 
|HOXA6as
 
|HOXA6as
 
|HOXA cluster antisense RNA 3
 
|HOXA cluster antisense RNA 3
 +
|_
 
|-
 
|-
 
|''HPVC1''
 
|''HPVC1''
 
|[[HPVC1]]
 
|[[HPVC1]]
−
|PE5L, HPV18E5L
+
|"PE5L, HPV18E5L"
 
|human papillomavirus (type 18) E5 central sequence-like 1
 
|human papillomavirus (type 18) E5 central sequence-like 1
 +
|_
 
|-
 
|-
 
|''HTT-AS''
 
|''HTT-AS''
Line 150: Line 183:
 
|HTTAS
 
|HTTAS
 
|HTT antisense RNA (head to head)
 
|HTT antisense RNA (head to head)
 +
|Huntington's disease
 
|-
 
|-
 
|''HULC''
 
|''HULC''
Line 155: Line 189:
 
|ENSG00000251164
 
|ENSG00000251164
 
|hepatocellular carcinoma up-regulated long non-coding RNA
 
|hepatocellular carcinoma up-regulated long non-coding RNA
 +
|hepatocelluar carcinoma, liver cancer
 
|-
 
|-
 
|''HYMAI''
 
|''HYMAI''
Line 160: Line 195:
 
|NCRNA00020
 
|NCRNA00020
 
|hydatidiform mole associated and imprinted (non-protein coding)
 
|hydatidiform mole associated and imprinted (non-protein coding)
 +
|_
 +
|-
 +
|''HCG11''
 +
|[[HCG11]]
 +
|bK14H9.3, FLJ14049, FLJ30357
 +
|HLA complex group 11 (non-protein coding)
 +
|prostate cancer
 +
|-
 +
|''HDAC2-AS2''
 +
|[[HDAC2-AS2]]
 +
|ENST00000421891
 +
|HDAC2 and HS3ST5 antisense RNA 2
 +
|early-onset preeclampsia
 +
|-
 +
|''HDHD5-AS1''
 +
|[[HDHD5-AS1]]
 +
|CECR4, CECR5-AS1, NCRNA00017
 +
|HDHD5 antisense RNA 1
 +
|cat eye syndrome
 +
|-
 +
|''HMMR-AS1''
 +
|[[HMMR-AS1]]
 +
|N/A
 +
|HMMR antisense RNA 1
 +
|basal-like breast cancer
 +
|-
 +
|''HSD17B3-AS1''
 +
|[[HSD17B3-AS1]]
 +
|ENST00000448857
 +
|HSD17B3 antisense RNA 1
 +
|early-onset preeclampsia
 +
|-
 +
|''HOXC-AS1''
 +
|[[HOXC-AS1]]
 +
|N/A
 +
|HOXC cluster antisense RNA 1
 +
|_
 
|}
 
|}

Latest revision as of 12:37, 29 June 2017

Jump to section in alphabetical order : A B C D E F G H I J K L M N O P R S T U V W X Y Z BACK

Name Transcript ID Alias Description Disease
H19 NONHSAT017465 "Q96MK8,ENSG00000130600" "H19, imprinted maternally expressed transcript (non-protein coding)" bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor
H1FX-AS1 H1FX-AS1 FLJ34151 H1FX antisense RNA 1 _
HAGLR ENST00000416928.2,NONHSAT075638 Mdgt HOXD antisense growth-associated long non-coding RNA neuroblastoma
HAND2-AS1 HAND2-AS1 "DEIN, NBLA00301, FLJ11539" HAND2 antisense RNA 1 (head to head) neuroblastoma
HAR1A lnc-BIRC7-2:1 "HAR1F, ENSG00000238820" highly accelerated region 1A Alzheimer's disease,Huntington's disease, schizophrenia
HAR1B ENST00000447910.2 "HAR1R, ENSG00000231133" highly accelerated region 1B Huntington's disease, schizophrenia
HAS2-AS1 HAS2-AS1 "HASNT, NCRNA00077" HAS2 antisense RNA 1 _
HCCAT5 HCCAT5 "HTA, FJ222407" hepatocellular carcinoma associated transcript 5 (non-protein coding) hepatocellular carcinoma
HCG27 HCG27 "bPG299F13.9, bCX101P6.9, bQB115I13.2, FLJ40123" HLA complex group 27 (non-protein coding) _
HCG4 HCG4 "HCGIV-10, HCGIV.9" HLA complex group 4 (non-protein coding) _
HCG4B HCG4B "HCGIV-6, HCGIV.5, HCGIV-06, bCX67J3.3, Em:AB023056.16, bPG309N1.1, bQB90C11.3" HLA complex group 4B (non-protein coding) _
HCG9 HCG9 "PERB11, HCGIX, HCGIX4, HCGIX-4" HLA complex group 9 (non-protein coding) _
HCP5 HCP5 "D6S2650E, P5-1" HLA complex P5 (non-protein coding) _
HEIH HEIH "LINC-HEIH, lncRNA-HEIH, LINC00848, HCCAT2" hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA hepatocelluar carcinoma
HELLPAR HELLPAR LINC-HELLP HELLP associated long non-coding RNA extravillous trophoblast
HEXA-AS1 HEXA-AS1 FLJ13315 HEXA antisense RNA 1 _
HIF1A-AS1 HIF1A-AS1 5'aHIF-1A HIF1A antisense RNA 1 kidney cancer
HIF1A-AS2 HIF1A-AS2 "3'aHIF-1A, aHIF" HIF1A antisense RNA 2 kidney cancer
HNF1A-AS1 HNF1A-AS1 FLJ38690 HNF1A antisense RNA 1 lung adenocarcinoma, oesophageal adenocarcinoma
HNF4A-AS1 HNF4A-AS1 uc002xlx HNF4A antisense RNA 1 _
HORMAD2-AS1 HORMAD2-AS1 "MTMR3-AS1, NONHSAG033653" HORMAD2 antisense RNA 1 _
HOTAIR NONHSAT028508 "Gm16258, Hox antisense intergenic RNA, ENSG00000228630" Hox antisense intergenic RNA B-cell neoplasms,breast cancer,cervical cancer,colon cancer,colorectal cancer,endometrial cancer,gastric cancer,hepatocelluar carcinoma,laryngeal squamous cell carcinoma,liver cancer,lung adenocarcinoma,nasopharyngeal carcinoma,non-small cell lung cancer,oesophageal squamous cell carcinoma,oral squamous cell carcinoma,pancreas cancer,rheumatoid arthritis,small cell lung cancer
HOTAIRM1 lnc-EVX1-12:1 "HIT06113, HIT92376, linc1548, ENSG00000233429" "HOXA transcript antisense RNA, myeloid-specific 1" _
HOTTIP NONHSAT119717 "HOXA13as, HIT18844, NCRNA00213, ENSG00000243766" HOXA transcript at the distal tip hepatocelluar carcinoma
HOXA11-AS NONHSAT119704 "HOXA cluster antisense RNA 5 (non-protein coding), HOXA-AS5, ""HOXA11 antisense RNA 1 (non-protein coding)"", HOXA11-AS1, HOXA11S, NCRNA00076, ""non-protein coding RNA 76"", ENSG00000240990" HOXA11 antisense RNA glioma, ovarian cancer
HOXA-AS2 NONHSAT119676 "HOXA3as, ENSG00000253552" HOXA cluster antisense RNA 2 gastric cancer
HOXA-AS3 lnc-EVX1-9:1 HOXA6as HOXA cluster antisense RNA 3 _
HPVC1 HPVC1 "PE5L, HPV18E5L" human papillomavirus (type 18) E5 central sequence-like 1 _
HTT-AS HTT-AS HTTAS HTT antisense RNA (head to head) Huntington's disease
HULC NONHSAT107640 ENSG00000251164 hepatocellular carcinoma up-regulated long non-coding RNA hepatocelluar carcinoma, liver cancer
HYMAI HYMAI NCRNA00020 hydatidiform mole associated and imprinted (non-protein coding) _
HCG11 HCG11 bK14H9.3, FLJ14049, FLJ30357 HLA complex group 11 (non-protein coding) prostate cancer
HDAC2-AS2 HDAC2-AS2 ENST00000421891 HDAC2 and HS3ST5 antisense RNA 2 early-onset preeclampsia
HDHD5-AS1 HDHD5-AS1 CECR4, CECR5-AS1, NCRNA00017 HDHD5 antisense RNA 1 cat eye syndrome
HMMR-AS1 HMMR-AS1 N/A HMMR antisense RNA 1 basal-like breast cancer
HSD17B3-AS1 HSD17B3-AS1 ENST00000448857 HSD17B3 antisense RNA 1 early-onset preeclampsia
HOXC-AS1 HOXC-AS1 N/A HOXC cluster antisense RNA 1 _
Retrieved from "https://ngdc.cncb.ac.cn/lncrnawiki1/index.php?title=LncRNAWiki:H&oldid=1273172"